Reading time: 6 minutes Shashank Gidipally, PharmD. Challenge of Bringing Precision Oncology to Skin Cancer Care in Community Settings In the last decade, skin cancer treatment has gone under a big shift. At first, treatments were limited to surgery, radiation, and chemotherapy. Now, practitioners have access to targeted genetic therapies and immunotherapies that have dramatically... Continue Reading →
Reading time: 5 minutes Joycelyn Ghansah, MA, MPH Active treatments like immunotherapy are used for various cancers, including melanoma, commonly known as skin cancer. Unfortunately, only about half of the patients respond to this type of treatment. Current research focuses on early prediction of skin cancers and identifying which patients are likely to respond positively... Continue Reading →
Reading time: 4 minutes Eoghan McGrath As a younger man peering across the kitchen table at my father’s scalp, I wondered if I was catching a glimpse of my own follicular future in its shiny freckled portents. Well, a decade, a degree in genetics, and a PhD in biochemistry later, I see my own scalp... Continue Reading →
Reading time: 4 minutes Brittany Avin McKelvey Climate change is a global issue with far-reaching effects on society. It is caused partly by greenhouse gases, including carbon dioxide, that trap the sun’s radiation in our atmosphere. While some warming and cooling effects are part of Earth’s natural cycle of climate change, the burning of fossil... Continue Reading →
Reading time: 3 minutes Morgan McSweeney Skin melanoma is the 5th most common type of cancer in the United States. Strikingly, 1 in 5 Americans develop skin cancer by the age of 70, and an average of 2 people die from skin cancer each hour. However, if detected while the tumor is still only present... Continue Reading →
Morgan McSweeney A group of researchers from the University of California - San Francisco recently found that the presence of a certain group of immune cells in tumors (“stimulatory dendritic cells,” or SDCs) can predict better cancer outcomes, at least in melanoma patients. For example, in patients treated with checkpoint inhibitors (drugs that work by... Continue Reading →
OncoBites 